A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis

AIM: To evaluate efficacy and safety of intravitreal aflibercept injection (IAI) in subjects who were previously treated with ranibizumab and/or bevacizumab for active exudative age-related macular degeneration (AMD). METHODS: Patients (n=26) were enrolled in a 12-month prospective, interventional,...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rishi P, Srivastava, Sunil, Ehlers, Justis P, Bedi, Rumneek, Schachat, Andrew P, Kaiser, Peter K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033174/
https://www.ncbi.nlm.nih.gov/pubmed/24836866
http://dx.doi.org/10.1136/bjophthalmol-2013-304798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033174/
https://www.ncbi.nlm.nih.gov/pubmed/24836866
http://dx.doi.org/10.1136/bjophthalmol-2013-304798

Ejemplares similares